entertainment -WSS

entertainment

author：Wikipedia 2025-10-01 18:22:51 - browse：48

The artificial womb, a device aiming to save infants born way too soon, is inching closer to being tested in humans.

The technology is close enough to reality that the Food and Drug Administration has decided to convene a two-day panel starting Tuesday to discuss how to best evaluate safety and effectiveness, as well as the ethical quandaries in running clinical trials. The second day will be closed to the public to shield trade secrets.

Several research teams are racing to build artificial placentas that replicate the uterine environment and give the very prematurely born a better shot at survival. A team at the Children’s Hospital of Philadelphia, led by Alan Flake, is the closest to human trials — their device is a bag filled with sterile fluid, which contains the fetus and is connected to tubes providing oxygen and nutrition.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： CDC: Uninsured rate hit 'record low' right as states cut Medicaid

focus

WSS

'Ancient DNA,' 23andMe reveal African American ancestries

White House drug shortage group privately met with industry

To avoid data mishandling cases, universities eye AI and other tools

The drug industry sees a key ally in the Senate prevail

What the cancer research community can learn from the Covid response

'Ancient DNA,' 23andMe reveal African American ancestries

hotspot

entertainment

hotspot

Medical records are filled with copy

Who is Magistrate Judge Moxila Upadhyaya in Trump's Jan. 6 case?

State Dept. review finds Biden bears some blame for Afghanistan failures

Readout LOUD podcast: How biotech is using artificial intelligence

Medicare details structure of new drug price negotiation program

Medicare threatens to cut off funding for HCA's Mission hospital

As demand for Covid shots wanes, Moderna seeks its next success

Stem cell clinics for heart failure: buyer be wary

Medical leaders decry Supreme Court decision on affirmative action

Attacks on the drug industry will lead to fewer breakthroughs

focus

Wild otter attack leads to woman being airlifted to hospital, 2 others treated for injuries

Dramatically reducing cancer deaths requires the PASTEUR Act

What should King Charles tell the public about his cancer?

Wild otter attack leads to woman being airlifted to hospital, 2 others treated for injuries

BioAge raises $170M for combination therapy with Zepbound

CDC: Uninsured rate hit 'record low' right as states cut Medicaid

entertainment

hotspot

focus

hotspot